128 related articles for article (PubMed ID: 31495016)
1. Screening vs staging magnetic resonance imaging-guided core needle breast biopsies: Does MRI indication impact upgrade rate?
Beaulieu-Jones BR; Ring N; Frazee TE; DiFlorio-Alexander RM; Rosenkranz KM
Breast J; 2020 Feb; 26(2):216-219. PubMed ID: 31495016
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
[TBL] [Abstract][Full Text] [Related]
3. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
[No Abstract] [Full Text] [Related]
4. High risk breast lesions identified on MRI-guided vacuum-assisted needle biopsy: outcome of surgical excision and imaging follow-up.
Speer ME; Huang ML; Dogan BE; Adrada BE; Candelaria RP; Hess KR; Hansakul P; Yang WT; Rauch GM
Br J Radiol; 2018 Oct; 91(1090):20180300. PubMed ID: 29947265
[TBL] [Abstract][Full Text] [Related]
5. High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.
Cha E; Ambinder EB; Oluyemi ET; Mullen LA; Panigrahi B; Rossi J; Di Carlo PA; Myers KS
Breast Cancer Res Treat; 2022 Dec; 196(3):517-525. PubMed ID: 36242709
[TBL] [Abstract][Full Text] [Related]
6. High-risk lesions at MRI-guided breast biopsy: frequency and rate of underestimation.
Lourenco AP; Khalil H; Sanford M; Donegan L
AJR Am J Roentgenol; 2014 Sep; 203(3):682-6. PubMed ID: 25148176
[TBL] [Abstract][Full Text] [Related]
7. Use of Breast Magnetic Resonance Imaging in Women Diagnosed With Atypical Ductal Hyperplasia at Core Needle Biopsy Helps Select Women for Surgical Excision.
Amitai Y; Menes T; Golan O
Can Assoc Radiol J; 2018 Aug; 69(3):240-247. PubMed ID: 29958833
[TBL] [Abstract][Full Text] [Related]
8. Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.
Cheeney S; Rahbar H; Dontchos BN; Javid SH; Rendi MH; Partridge SC
J Magn Reson Imaging; 2017 Oct; 46(4):1028-1036. PubMed ID: 28181343
[TBL] [Abstract][Full Text] [Related]
9. The risk of upgrade for atypical ductal hyperplasia detected on magnetic resonance imaging-guided biopsy: a study of 100 cases from four academic institutions.
Khoury T; Li Z; Sanati S; Desouki MM; Chen X; Wang D; Liu S; Karabakhtsian R; Kumar P; Reig B
Histopathology; 2016 Apr; 68(5):713-21. PubMed ID: 26291517
[TBL] [Abstract][Full Text] [Related]
10. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
11. Correlation between core biopsy and excisional biopsy in breast high-risk lesions.
Margenthaler JA; Duke D; Monsees BS; Barton PT; Clark C; Dietz JR
Am J Surg; 2006 Oct; 192(4):534-7. PubMed ID: 16978969
[TBL] [Abstract][Full Text] [Related]
12. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
Strigel RM; Eby PR; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462
[TBL] [Abstract][Full Text] [Related]
13. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
[TBL] [Abstract][Full Text] [Related]
14. Pathologic Findings of Breast Lesions Detected on Magnetic Resonance Imaging.
Jabbar SB; Lynch B; Seiler S; Hwang H; Sahoo S
Arch Pathol Lab Med; 2017 Nov; 141(11):1513-1522. PubMed ID: 28782985
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sonographically guided core needle biopsy and excision in breast papillomas: clinical and sonographic features predictive of malignancy.
Sohn YM; Park SH
J Ultrasound Med; 2013 Feb; 32(2):303-11. PubMed ID: 23341387
[TBL] [Abstract][Full Text] [Related]
16. Surgical upgrade rate of breast atypia to malignancy: An academic center's experience and validation of a predictive model.
Linsk A; Mehta TS; Dialani V; Brook A; Chadashvili T; Houlihan MJ; Sharma R
Breast J; 2018 Mar; 24(2):115-119. PubMed ID: 28833923
[TBL] [Abstract][Full Text] [Related]
17. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
Rendi MH; Dintzis SM; Lehman CD; Calhoun KE; Allison KH
Ann Surg Oncol; 2012 Mar; 19(3):914-21. PubMed ID: 21861212
[TBL] [Abstract][Full Text] [Related]
18. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy.
Liberman L; Holland AE; Marjan D; Murray MP; Bartella L; Morris EA; Dershaw DD; Wynn RT
AJR Am J Roentgenol; 2007 Mar; 188(3):684-90. PubMed ID: 17312054
[TBL] [Abstract][Full Text] [Related]
19. Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography.
Lamb LR; Bahl M; Hughes KS; Lehman CD
J Am Coll Surg; 2018 May; 226(5):858-867. PubMed ID: 29410346
[TBL] [Abstract][Full Text] [Related]
20. The Positive Outcome of MRI-Guided Vacuum Assisted Core Needle Breast Biopsies Is Not Influenced by a Prior Negative Targeted Second-Look Ultrasound.
Ferré R; AlSharif S; Aldis A; Mesurolle B
Can Assoc Radiol J; 2017 Nov; 68(4):401-408. PubMed ID: 28835335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
